Could Lesional BAFF Act As A "Sink" For Zura's Tibulizumab In Hidradenitis Suppurativa?
A computational PK simulation of BAFF release in hidradenitis suppurativa lesions suggests that locally accumulating BAFF is unlikely to consume a relevant share of tibulizumab at 150 or 300 mg.